By Jack Coates
In May 2001, I was diagnosed with medullablastoma. I was 19 years old and had just finished my freshman year at Johnson & Wales University in Rhode Island.
Medullablastoma is a cancer that affects the brain and the spine. I had three surgeries, 52 weeks of chemo, and six weeks of radiation. I spent a year and two months in the hospital and went from 217 pounds to 97. I was scared. I was asking God: “Why? Why did it have to happen to me?” It was shocking. Many things went through my mind.
On Thanksgiving Day every year, Marc Kutzer and his sister, Roberta Klein, have much to be thankful for.
In 2001, Kutzer went to his primary care physician for a routine physical. What his doctor discovered led Kutzer, 52, to Dana-Farber — and to a procedure he credits for saving not only his life, but also his sister’s. Read more
by Erica Mayer, MD, MPH
In 1974, when First Lady Betty Ford announced that she had undergone a mastectomy for breast cancer, it was a turning point in people’s willingness to talk about the disease. Prior to that, discussing cancer of any type, even with one’s family or friends, was often taboo. The First Lady’s openness about her cancer helped create a space in which women felt more comfortable talking about their experience – and about being screened for the disease.
When Good Morning America host Robin Roberts revealed that she has myelodysplastic syndrome (MDS), she turned a spotlight on a group of blood disorders that affect an estimated 35,000 to 55,000 people in the United States.
In patients with MDS, the bone marrow fails to produce normal quantities of blood cells and the cells themselves are often abnormal, resulting in anemia and an array of symptoms including paleness, fatigue, susceptibility to infections, and easy bruising or bleeding. The syndrome, of which there are at least 15,000 new diagnoses each year in the United States, formerly was known as “pre-leukemia” because about one-third of patients go on to develop acute myelogenous leukemia (AML).